Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1111/bjh.12985

Type

Journal article

Journal

Br J Haematol

Publication Date

11/2014

Volume

167

Pages

418 - 420

Keywords

CALR, JAK inhibition, myeloproliferative disease, Anemia, Humans, Janus Kinase 1, Janus Kinase 2, Maximum Tolerated Dose, Primary Myelofibrosis, Protein Kinase Inhibitors, Pyrazoles, Recurrence, Splenomegaly, Symptom Assessment, Thrombocytopenia